Contineum Therapeutics, Inc. ( CTNM) - Stock Earnings
CTNM Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 29, 2026, midnight | — / — | — | — / — | — |
CTNM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -15.2 million USD | — USD |
| 2026Q1 | -14.5 million USD | — USD |
| 2026Q2 | -15.2 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CTNM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 22.7 million USD | 50.0 million USD |
| 2024 | -42.3 million USD | — USD |
| 2025 | -60.0 million USD | — USD |
| 2026 Est. | — | — |
CTNM
Price: $8
52 week price:
Earnings Per Share: -1.66 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 475.9 million